日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages

帕博利珠单抗治疗复发性胶质母细胞瘤患者的窗口期临床试验揭示了免疫抑制性巨噬细胞的优势地位

John de Groot ,Marta Penas-Prado ,Kristin Alfaro-Munoz ,Kathy Hunter ,Be Lian Pei ,Barbara O'Brien ,Shiao-Pei Weathers ,Monica Loghin ,Carlos Kamiya Matsouka ,W K Alfred Yung ,Jacob Mandel ,Jimin Wu ,Ying Yuan ,Shouhao Zhou ,Gregory N Fuller ,Jason Huse ,Ganesh Rao ,Jeffrey S Weinberg ,Sujit S Prabhu ,Ian E McCutcheon ,Frederick F Lang ,Sherise D Ferguson ,Raymond Sawaya ,Rivka Colen ,Shalini S Yadav ,Jorge Blando ,Luis Vence ,James Allison ,Padmanee Sharma ,Amy B Heimberger